The Effect of Microbubble-Assisted Ultrasound on Molecular Permeability across Cell Barriers
Authors:
- Charis RousouCRCharis Rousou
- Josanne de MaarJMJosanne de Maar
- Boning QiuBQBoning Qiu
- Kim van der Wurff-JacobsKWKim van der Wurff-Jacobs
- Marika RuponenMRMarika Ruponen
- Arto UrttiAUArto Urtti
- Sabrina OliveiraSOSabrina Oliveira
- Chrit MoonenCMChrit Moonen
- Gert StormGSGert Storm
- Enrico MastrobattistaEnrico Mastrobattista
- Roel DeckersRDRoel Deckers
Open Access
- 24 February 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (3) , 494
Abstract
The combination of ultrasound and microbubbles (USMB) has been applied to enhance drug permeability across tissue barriers. Most studies focused on only one physicochemical aspect (i.e., molecular weight of the delivered molecule). Using an in vitro epithelial (MDCK II) cell barrier, we examined the effects of USMB on the permeability of five molecules varying in molecular weight (182 Da to 20 kDa) and hydrophilicity (LogD at pH 7.4 from 1.5 to highly hydrophilic). Treatment of cells with USMB at increasing ultrasound pressures did not have a significant effect on the permeability of small molecules (molecular weight 259 to 376 Da), despite their differences in hydrophilicity (LogD at pH 7.4 from −3.2 to 1.5). The largest molecules (molecular weight 4 and 20 kDa) showed the highest increase in the epithelial permeability (3-7-fold). Simultaneously, USMB enhanced intracellular accumulation of the same molecules. In the case of the clinically relevant anti- C-X-C Chemokine Receptor Type 4 (CXCR4) nanobody (molecular weight 15 kDa), USMB enhanced paracellular permeability by two-fold and increased binding to retinoblastoma cells by five-fold. Consequently, USMB is a potential tool to improve the efficacy and safety of the delivery of drugs to organs protected by tissue barriers, such as the eye and the brain.Keywords
Funding Information
- European Union’s Horizon 2020 (722717)
This publication has 55 references indexed in Scilit:
- Targeted and Reversible Blood-Retinal Barrier Disruption via Focused Ultrasound and MicrobubblesPLOS ONE, 2012
- Sonophoresis Using Ultrasound Contrast Agents for Transdermal Drug Delivery: An In Vivo Experimental StudyUltrasound in Medicine & Biology, 2012
- CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cellsProceedings of the National Academy of Sciences, 2010
- Transdermal Drug Delivery Aided by an Ultrasound Contrast Agent: An In Vitro Experimental StudyThe Open Biomedical Engineering Journal, 2010
- Effect of Focused Ultrasound Applied With an Ultrasound Contrast Agent on the Tight Junctional Integrity of the Brain Microvascular EndotheliumUltrasound in Medicine & Biology, 2008
- Ultrasound Enhanced Delivery of Molecular Imaging and Therapeutic Agents in Alzheimer's Disease Mouse ModelsPLOS ONE, 2008
- Molecular Basis of Epithelial Barrier RegulationThe American Journal of Pathology, 2006
- Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood–brain barrier disruptionProceedings of the National Academy of Sciences, 2006
- Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformabilityAmerican Journal of Physiology-Renal Physiology, 2005
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991